Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Tourette Syndrome and ADHD
NCT00004376Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Sep 1994
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of guanfacine in Tourette syndrome (TS), attention deficit hyperactivity disorder (ADHD), sponsored by National Center for Research Resources. Started Sep 1994; status: completed.
02
Drugs
guanfacine
03
Conditions
Tourette syndrome (TS)attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00004376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004376.